Artificial Intelligence

With its CFO at a key forum, Syntiant leverages 100M+ chip deployments to prove the value of on-device intelligence in a booming multi-billion dollar market.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

A new partnership brings AI voice analysis to home caregiving, promising proactive support for seniors but raising new questions about privacy in our living rooms.

At Abarca Forward 2026, industry stakeholders and federal officials built a new playbook to transform the universally broken prior authorization process.

At MWC 2026, IP Infusion launched OcNOS 7.0, targeting AI data centers and 400G/800G optical transport with an open, cost-saving platform.

Oat Foundry launches Chroma Flap, a vibrant kinetic wall that uses mechanical motion and sound to transform interiors into living, multi-sensory art.

Motel 6's parent company is rolling out an advanced AI security system across 1500+ hotels to fight trafficking, but it raises new questions about guest surveillance.

IMO Health integrates a global rare disease database into EHRs, promising to shorten diagnosis times and accelerate vital research for millions.

Austin startup Path unveils its AI-native platform, enabling businesses to build adaptive software systems without traditional coding barriers.

A new partnership in the Carolinas is creating a vital material for AI chips, aiming to strengthen US tech independence and secure the semiconductor supply chain.

A private market index tracking tech giants like SpaceX surged nearly 200% in 14 months, raising questions about a new, exclusive tier of wealth creation.

In a strategic push into critical infrastructure, GCG's latest acquisition of a family-owned cable specialist signals a major play for the data center market.

A new AI tool reads medical reports to find overlooked, life-threatening conditions, bridging a dangerous communication gap between doctors and patients.

The sports betting aggregator launches AtlasDFS, an integrated Pick'em game, aiming to become an all-in-one hub for fans amid fierce regulatory headwinds.

The new Medicare-covered platform combines human advocates with an AI companion to help older adults and caregivers navigate the complex healthcare system.

Mahzi Therapeutics has dosed its first patient in a landmark study, offering a potential breakthrough for a rare and severe neurogenetic disorder.

With $3M in funding, TBD is using biometric verification and prediction markets to find out what people really think in a world saturated with bots.

One River Asset Management acquires LGT's quant team and $900M+ in strategies, establishing a Swiss base and bolstering its systematic risk offerings.

As the U.S. faces a staggering physician deficit, recruitment leaders convene to tackle talent wars, immigration hurdles, and the future of patient care.

Amid a surge in MedTech M&A, Piper Sandler appoints 25-year veteran Aamer Naseer to steer its life sciences outsourcing and B2B technology groups.